Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines for the Management of Cholestatic Liver Diseases (2021)
Lungen Lu
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 4, pp. 757-769
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats
Doaa Adnan Atshan, Munaf H. Zalzala
Current Research in Pharmacology and Drug Discovery (2024) Vol. 6, pp. 100177-100177
Open Access | Times Cited: 8
Alkaline phosphatase activatable near-infrared fluorescent probe for in-situ diagnosis of cholestatic liver injury
Jiao Chen, Jinxin Li, Zihan Zhang, et al.
Sensors and Actuators B Chemical (2024) Vol. 413, pp. 135896-135896
Closed Access | Times Cited: 6
Bile Acids in Intrahepatic Cholestasis of Pregnancy
Maciej Majsterek, Magdalena Wierzchowska-Opoka, Inga Makosz, et al.
Diagnostics (2022) Vol. 12, Iss. 11, pp. 2746-2746
Open Access | Times Cited: 25
Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?
Xin Luo, Lungen Lu
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 6, pp. 581-588
Open Access | Times Cited: 5
Pruritus
T. S. Dharmarajan, Dattu Vyas
(2025), pp. 1-27
Closed Access
Recent advances in diagnosis and management of chronic cholestatic liver diseases: expert consensus
Shrikant Mukewar
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 2, pp. 967-976
Open Access
Updates in chronic cholestatic liver diseases: Indian expert recommendations for diagnosing and managing complex cases
Manav Wadhawan
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 2, pp. 949-957
Open Access
Ellagic acid mitigates alpha-naphthyl isothiocyanate-induced cholestasis in rats via FXR activation and inflammatory pathway modulation
Huda Mawlood Taher, Munaf H. Zalzala
Journal of Complementary and Integrative Medicine (2025)
Closed Access
Cholestatic liver diseases: modern therapeutics
Bridgette B. McNally, Elizabeth J. Carey
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Benign Recurrent Intrahepatic Cholestasis: Where Are We Now?
Eleni Geladari, Natalia G. Vallianou, Evangelia Margellou, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 1, pp. 156-167
Open Access | Times Cited: 3
Therapeutic options for the management of the cholestatic phase of viral hepatitis A and E – A systematic review
Suprabhat Giri, Gaurav Khatana, Prasanna Gore, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102557-102557
Closed Access
Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling
Wei Su, Shuping Song, Jieqiong Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties
Ala Mohagheghzadeh, Parmis Badr, Abdolali Mohagheghzadeh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 887-887
Open Access | Times Cited: 6
Possible Protective Effect of Low Dose of Papaverine on ANIT Induce Cholestasis in Rat
Doaa Adnan Atshan, Munaf H. Zalzala
Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) (2023) Vol. 32, Iss. Suppl., pp. 118-126
Open Access | Times Cited: 4
Arachidonic acid enhances hepatocyte bile acid uptake and alleviates cholestatic liver disease by upregulating OATP1 expression
Yanlu Ma, Chen Zou, Yilan Yang, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9916-9927
Closed Access | Times Cited: 1
The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes
Jun Han, Peijie Wu, Yueqiang Wen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies—A Case-Control Study
Serena Ammendola, Sara Romeo, Filippo Cattazzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 784-784
Open Access
Cost-effectiveness analysis of S-ademetionine compared with ursodeoxycholic acid for the treatment of Intrahepatic Cholestasis in China
Han‐Soo Kim, Juntao Lyu, Ruth Royle, et al.
Research Square (Research Square) (2024)
Open Access
A Comparative Analysis of ADRs under Obeticholic Acid and Ursodeoxycholic Acid in Cholestatic Liver Diseases Using the FAERS Database
Mengqing Zhu, Linghui Tao, Feiye Zhu, et al.
Drug Research (2024)
Closed Access
The non-HDL-C to APOB ratio as a predictor of inaccurate LDL-C measurement in patients with chronic intrahepatic cholestasis and jaundice: a retrospective study
Yongjiang Cheng, Jingyan Ye, Junyuan Huang, et al.
PeerJ (2024) Vol. 12, pp. e18224-e18224
Open Access
Efficacy and Safety of Ileal Bile Acid Transport Inhibitors in Inherited Cholestatic Liver Disorders: A Meta-analysis of Randomized Controlled Trials.
Muhammad Imran, Ahmed Bostamy Elsnhory, Ahmed A. Ibrahim, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 3, pp. 102462-102462
Closed Access
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives
Alberto Savino, A. Rossi, S. Fagiuoli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 76-76
Open Access
Benign Recurrent Intrahepatic Cholestasis: Where are we now?
Eleni Geladari, Natalia G. Vallianou, Evangelia Margellou, et al.
(2023)
Open Access | Times Cited: 1
Effectiveness of oral methylprednisolone as adjuvant therapy for clinical improvement, biochemical markers, and inflammation in infants with cholestasis
Bagus Setyoboedi, Martono Tri Utomo, Rendi Aji Prihaningtyas, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34110-e34110
Open Access
A Genes & Health pilot recall study of intrahepatic cholestasis of pregnancy and cholestatic liver disease
Manolis Constantinides, Joseph Gafton, Antonio M. Garcia, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top